When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TCON - Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xencor In $480 Million Deal
TRACON Pharmaceuticals Inc.
In a $480 million deal, Zenas, a Shanghai-Boston biopharma, acquired global rights to a bifunctional antibody from Xencor that targets CD19.
Beijing's BeiGene closed on a 42-acre US site in the Princeton, NJ area where it will build a manufacturing center and house clinical R&D operations.
3D Medicines reported that China's NMPA approved the launch of its anti-PD-L1 therapy, the first subcutaneously administered anti-PD-L1 approved anywhere in the world.